|
Kinetics of humoral immunodeficiency with bispecific antibody therapy in multiple myeloma. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Celgene; GlaxoSmithKline; Karyopharm Therapeutics; Sanofi |
Consulting or Advisory Role - Amgen; GlaxoSmithKline; Janssen Oncology; Natera; Sanofi; Takeda |
Research Funding - Amgen (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst) |
|
Sabarinath Venniyil Radhakrishnan |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Akcea Therapeutics; Bristol-Myers Squibb/Celgene; Janssen Oncology; Pfizer; Prothena |
Research Funding - Abbvie; Caelum Biosciences (Inst); Janssen Oncology; Prothena (Inst); Regeneron; Sanofi (Inst); Takeda (Inst); TeneoBio (Inst) |
Travel, Accommodations, Expenses - Imbrium Therapeutics |
|
|
Research Funding - Celgene/Bristol-Myers Squibb (Inst); Novartis (Inst); Takeda (Inst) |